Vayacog By Vaya Overview & Drug Interactions
Check For Interactions With Vayacog
Supplement: Vayacog by Vaya
Vayacog Label Images
This product contains
Below is a list of the 'active' ingredients listed on the supplement label for this product.
For a list of 'other ingredients', such as fillers, please see the 'Label Information' section on this page.
Lipicogen
| Ingredient Group | Proprietary Blend (Fatty Acid or Fat/Oil supplement) |
|---|---|
| Category | blend |
-
Phosphatidylserine
Description:Phosphatidylserine is a phospholipid that plays a crucial role in cell structure and function, particularly in the brain. It's a key component of cell membranes, aiding in cell signaling and maintaining cellular integrity. In the context of the brain, phosphatidylserine supports cognitive function, memory, and neurotransmitter regulation. Additionally, it's commonly used as a dietary supplement to potentially enhance cognitive performance and mitigate age-related cognitive decline.
See More Information Regarding Phosphatidylserine
Ingredient Group Phosphatidylserine Category fat
-
Omega-3 Fatty Acids
Ingredient Group Omega-3 Category fatty acid
-
Docosahexaenoic Acid
Ingredient Group DHA (Docosahexaenoic Acid) Category fatty acid
-
-
Drugs that interact with Vayacog by Vaya
Below is a list of drug interactions for each ingredient in this supplement product. Please note that a supplement product may contain more than one ingredient that has interactions.
Label Information
Supplement Facts:
| Daily Value (DV) Target Group(s): | Adults and children 4 or more years of age |
|---|---|
| Minimum serving Sizes: |
1 Not Present
|
| Maximum serving Sizes: |
1 Not Present
|
| Ingredient | Amount per Serving | Group | % DV, Adults & children 4+ years |
|---|---|---|---|
| Lipicogen |
100 mg
|
Proprietary Blend (Fatty Acid or Fat/Oil supplement) |
|
| Phosphatidylserine |
0 NP
|
Phosphatidylserine |
|
| Omega-3 Fatty Acids |
0 NP
|
Omega-3 |
|
| Docosahexaenoic Acid |
0 NP
|
DHA (Docosahexaenoic Acid) |
|
| Other Ingredients: |
Phosphatidylserine
Maltodextrin
Hydroxypropyl Methylcellulose
Silicon Dioxide
Contains less than 1% of
Forms
|
|---|
Label Statments:
| Formulation |
- For dietary management of early memory impairment
For the clinical dietary management of lipid imbalances associated with early memory impairment
Clinically shown to improve
Recall
Long term memory
Learning abilities
Prove safe
Description
Vayacog is an orally administered medical food for the clinical dietary management of complex lipid imbalances associated with early memory impairment. Vayacog is a specially formulated and processed composition designed to address the distinct medically determined lipid nutritional requirements of people with early memory impairment, the dietary management of which cannot be achieved by modification of the normal diet or use of dietary supplements.
- Vayacog capsules do not contain sugar, lactose, yeast or gluten.
- Indication and usage
Vayacog, an orally administered medical food for the clinical dietary management of early memory impairment, is designed to address the distinct, medically determined nutritional requirements of early memory impairment, the dietary management of which cannot be achieved by modification of the normal diet alone.
|
|---|---|
| Formula |
- Lipicogen is a proprietary composition containing phosphatidylserine (PS) conjugated to omega-3 fatty acids enriched with Docosahexaenoic acid (DHA).
|
| Precautions |
- Medical Supervision
Vayacog is a medical food product intended for use under supervision of a physician or licensed healthcare provider.
- Vayacog capsules contain soy and fish (Herring and/or Blue Whiting)
- Contraindications
Vayacog is contraindicated in patients with known hypersensitivity (e.g., anaphylactic reaction) to Vayacog or any of its components.
- Precautions
Safety and effectiveness of Vayacog in pediatric patients or pregnant or lactating patients have not been established. Therefore, Vayacog is not recommended for these populations.
- Precautions
Safety and effectiveness of Vayacog in pediatric patients or pregnant or lactating patients have not been established. Therefore, Vayacog is not recommended for these populations.
- Vayacog should be used with caution in patients with known hypersensitivity to soy and/or fish.
- Warning
Keep this product out of the reach of children.
|
| Suggested/Recommended/Usage/Directions |
- Dosage and administration
Usual dose is one capsule daily or as directed by a physician.
|
| Storage |
- Storage
Store at up to 77 degrees F (25 degrees C). Protect from light and moisture.
|
| Brand IP Statement(s) |
- Vayacog and Lipicogen are registered trademarks of Enzymotec Ltd.
US Patents No. 7,935,365; 7,968,112; 8,975,299; 8,470,345; 8,568,773 and 9,168,310.
|
| FDA Statement of Identity |
- Medical food
|
Brand Information
See all products by this brand
| Distributed by | |
|---|---|
| Name | Vaya Pharma Inc. |
| Street Address | 10480 Little Patuxent Pkwy |
| City | Columbia |
| State | Maryland |
| ZipCode | 21044 |
Return to the main supplement interaction checker page
Parts of this content are provided by the Therapeutic Research Center, LLC and the Dietary Supplement Label Database.
DISCLAIMER: Currently this does not check for drug-drug interactions. This is not an all-inclusive comprehensive list of potential interactions and is for informational purposes only. Not all interactions are known or well-reported in the scientific literature, and new interactions are continually being reported. Input is needed from a qualified healthcare provider including a pharmacist before starting any therapy. Application of clinical judgment is necessary.
© 2021 Therapeutic Research Center, LLC
Drug descriptions are provided by MedlinePlus.